Literature DB >> 16397140

Tissue factor encryption.

Ronald R Bach1.   

Abstract

Tissue factor (TF) encryption is the post-translational suppression of TF procoagulant activity (PCA) on the cell surface. There is emerging evidence of encrypted TF in normal blood associated with monocytes and platelets. Expression of this latent TF PCA during the propagation phase of blood coagulation may contribute to hemostasis. One pathway leading to the decryption of TF PCA begins with an increase in cytosolic calcium. A large calcium influx triggers both the exposure of phosphatidylserine and the expression of TF PCA on cell surfaces. The connections between these events are reviewed along with evidence that lipid raft association may also contribute to TF encryption. The last step in the decryption of TF PCA is the proteolytic activation of zymogen factor VII. This event may be a key to understanding the different roles of intravascular and extravascular TF in the process of blood coagulation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16397140     DOI: 10.1161/01.ATV.0000202656.53964.04

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  90 in total

Review 1.  Decryption of tissue factor.

Authors:  Saulius Butenas; Jolanta Krudysz-Amblo
Journal:  Thromb Res       Date:  2012-03-07       Impact factor: 3.944

2.  Cryptic messages: is noncoagulant tissue factor reserved for cell signaling?

Authors:  Eric Camerer; Joann Trejo
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-19       Impact factor: 11.205

3.  Acid sphingomyelinase plays a critical role in LPS- and cytokine-induced tissue factor procoagulant activity.

Authors:  Jue Wang; Usha R Pendurthi; L Vijaya Mohan Rao
Journal:  Blood       Date:  2019-07-01       Impact factor: 22.113

Review 4.  Tissue factor and tissue factor pathway inhibitor as key regulators of global hemostasis: measurement of their levels in coagulation assays.

Authors:  Raj S Kasthuri; Sam L Glover; Jeremiah Boles; Nigel Mackman
Journal:  Semin Thromb Hemost       Date:  2010-10-26       Impact factor: 4.180

5.  Bovine protein disulfide isomerase-enhanced tissue factor coagulant function: is phospholipid contaminant in it the real culprit?

Authors:  Hema Kothari; Prosenjit Sen; Usha R Pendurthi; L Vijaya Mohan Rao
Journal:  Blood       Date:  2008-03-15       Impact factor: 22.113

6.  Hemolysis-associated hypercoagulability in sickle cell disease: the plot (and blood) thickens!

Authors:  Mark T Gladwin; Gregory J Kato
Journal:  Haematologica       Date:  2008-01       Impact factor: 9.941

7.  Loop dynamics of the extracellular domain of human tissue factor and activation of factor VIIa.

Authors:  Agnese S Minazzo; Reuben C Darlington; J B Alexander Ross
Journal:  Biophys J       Date:  2009-01       Impact factor: 4.033

8.  Tissue factor regulation by epidermal growth factor receptor and epithelial-to-mesenchymal transitions: effect on tumor initiation and angiogenesis.

Authors:  Chloe C Milsom; Joanne L Yu; Nigel Mackman; Johann Micallef; G Mark Anderson; Abhijit Guha; Janusz W Rak
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

Review 9.  Breast cancer phenotypes regulated by tissue factor-factor VII pathway: Possible therapeutic targets.

Authors:  Shiro Koizume; Yohei Miyagi
Journal:  World J Clin Oncol       Date:  2014-12-10

10.  Thioredoxin and thioredoxin reductase control tissue factor activity by thiol redox-dependent mechanism.

Authors:  Pei Wang; Yunfei Wu; Xiaoming Li; Xiaofeng Ma; Liangwei Zhong
Journal:  J Biol Chem       Date:  2012-12-07       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.